4E-BP1 Antibody

About the Target

EIF4EBP1 is a target of interest in many antibody-based workflows. Eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) belongs to a family of proteins that suppress translation and is a well-known target of the mechanistic target of rapamycin (mTOR) signaling pathway. Multiple residues on 4E-BP1 undergo phosphorylation in vivo. While phosphorylation by FRAP/mTOR at Thr37 and Thr46 does not impede the binding of 4E-BP1 to eIF4E, it is thought to prepare 4E-BP1 for subsequent phosphorylation at Ser65 and Thr70. Depending on the literature source, EIF4EBP1 may also be discussed as 4E-BP1 and Eukaryotic translation initiation factor 4E-binding protein 1.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following EIF4EBP1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EIF4EBP1 is commonly interpreted in the context of cancer, angiogenesis, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• differences related to endothelial activation, vessel remodeling, or growth-factor exposure
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EIF4EBP1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EIF4EBP1 reflect biology rather than handling. When interpreting EIF4EBP1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EIF4EBP1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.